These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21326087)

  • 1. Modulation of toll-like receptors by insulin.
    Tilich M; Arora RR
    Am J Ther; 2011 Sep; 18(5):e130-7. PubMed ID: 21326087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs).
    Franchini M; Zini E; Osto M; Jablonski K; Kaufmann K; Lutz TA; Reusch CE; Ackermann M
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):70-8. PubMed ID: 20674989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors, inflammation, metabolism and obesity.
    Fresno M; Alvarez R; Cuesta N
    Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of toll-like receptors in human diseases.
    Montero Vega MT; de Andrés Martín A
    Allergol Immunopathol (Madr); 2009; 37(5):252-63. PubMed ID: 19853360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and modulating the Toll like Receptors (TLRs) and NOD like Receptors (NLRs) cross talk in type 2 diabetes.
    Prajapati B; Jena PK; Rajput P; Purandhar K; Seshadri S
    Curr Diabetes Rev; 2014 May; 10(3):190-200. PubMed ID: 24828062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors as targets for immune disorders.
    Keogh B; Parker AE
    Trends Pharmacol Sci; 2011 Jul; 32(7):435-42. PubMed ID: 21529972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of toll-like receptor and cytokine signaling--a unifying theme in ischemic tolerance.
    Karikó K; Weissman D; Welsh FA
    J Cereb Blood Flow Metab; 2004 Nov; 24(11):1288-304. PubMed ID: 15545925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders.
    Fukata M; Vamadevan AS; Abreu MT
    Semin Immunol; 2009 Aug; 21(4):242-53. PubMed ID: 19748439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.
    Loppnow H; Werdan K; Buerke M
    Innate Immun; 2008 Apr; 14(2):63-87. PubMed ID: 18713724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collaboration between the innate immune receptors dectin-1, TLRs, and Nods.
    Underhill DM
    Immunol Rev; 2007 Oct; 219():75-87. PubMed ID: 17850483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory pathways in malaria infection: TLRs share the stage with other components of innate immunity.
    Erdman LK; Finney CA; Liles WC; Kain KC
    Mol Biochem Parasitol; 2008 Dec; 162(2):105-11. PubMed ID: 18804125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptors in tonsillar epithelial cells.
    Lange MJ; Lasiter JC; Misfeldt ML
    Int J Pediatr Otorhinolaryngol; 2009 Apr; 73(4):613-21. PubMed ID: 19167100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors and innate immunity.
    Kumar H; Kawai T; Akira S
    Biochem Biophys Res Commun; 2009 Oct; 388(4):621-5. PubMed ID: 19686699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and increased lipolysis in bone marrow derived adipocytes stimulated with agonists of Toll-like receptors.
    Franchini M; Monnais E; Seboek D; Radimerski T; Zini E; Kaufmann K; Lutz T; Reusch C; Ackermann M; Muller B; Linscheid P
    Horm Metab Res; 2010 Sep; 42(10):703-9. PubMed ID: 20603780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLRs in the Gut. IV. Negative regulation of Toll-like receptors and intestinal homeostasis: addition by subtraction.
    Shibolet O; Podolsky DK
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1469-73. PubMed ID: 17554134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.